As the leading cause of preventable blindness in working-age adults, diabetic retinopathy (DR) affects 40% to 45% of diabetic patients.
1 In the United States alone, the number of DR patients is estimated to increase from 7.7 million in 2010 to 14.6 million by 2050.
1 Early detection, prompt intervention, and reliable assessment of treatment outcomes are essential to preventing irreversible visual loss from DR. With early detection and adequate treatment, more than 95% of DR-related vision losses can be prevented.
2 Retinal vascular abnormalities, such as microaneurysms, hard exudates, retinal edema, venous beading, intraretinal microvascular anomalies, and retinal hemorrhages, are common DR findings.
3 Therefore, imaging examination of retinal vasculature is important for DR diagnosis and treatment evaluation. Traditional fundus photography provides limited sensitivity to reveal subtle abnormality correlated with early DR.
4–7 Fluorescein angiography (FA) can be used to improve imaging sensitivity of retinal vascular distortions in DR
8,9; however, FA requires intravenous dye injections, which may produce side effects and require additional monitoring and careful management. Optical coherence tomography angiography (OCTA) is a noninvasive method for better visualization of retinal vasculatures.
10 OCTA allows visualization of multiple retinal layers with high resolution; thus, it is more sensitive than FA in detecting subtle vascular distortions correlated with early eye conditions.
11–13
The recent development of quantitative OCTA offers a unique opportunity to utilize computer-aided disease detection and artificial intelligence (AI) classification of eye conditions. Quantitative OCTA analysis has been explored for objective assessment of, for example, DR,
14–17 age-related macular degeneration (AMD),
18,19 vein occlusion,
20–23 and sickle cell retinopathy (SCR).
24 Supervised machine learning has also recently been validated for multiple-task classification to differentiate among control, DR, and SCR eyes.
25 In principle, deep learning may provide a simple solution to fostering clinical deployment of AI classification of OCTA images. Deep learning generally refers to the convolutional neural network (CNN) algorithm, which was inspired by the human brain and visual information processing. CNNs contain millions of artificial neurons (also referred to as parameters) to process image features in a feed-forward process by extracting and processing simple features in early layers and complex features in later layers.
26 To train a CNN for a specific classification task requires millions of images to optimize the network parameters.
27 However, for the relatively new imaging modality OCTA, the limitation of currently available images poses an obstacle for practical implementation of deep learning.
In order to overcome the limitation of data size, a transfer learning approach has been demonstrated for implementing deep learning. Transfer learning is a training method to adopt some weights of a pretrained CNN and appropriately retrain certain layers of that CNN to optimize the weights for a specific task (i.e., AI classification of retinal images).
28 In fundus photography, transfer learning has been explored to conduct artery–vein segmentation,
29 glaucoma detection,
30,31 and diabetic macular thinning assessment.
32 Recently, transfer learning has also been explored in OCT for detecting choroidal neovascularization, diabetic macular edema,
28 and AMD.
33
In principle, transfer learning can involve a single layer or multiple layers, because each layer has weights that can be retrained. For example, the specific number of layers required for retraining in a 16-layer CNN (
Fig. 1) may vary, depending on the available dataset and specific task interested. Moreover, compared to traditional fundus photography and OCT, deep learning in OCTA classification is still unexplored due to the limited size of publicly available datasets. In this study, we demonstrate the first use of OCTA for automated classification using deep learning. By leveraging transfer learning, we aim to train a small dataset to achieve reliable DR classification. Furthermore, an easy-to-use graphical user interface (GUI) platform was also developed to foster deep-leaning-based DR classification for adoption in a clinical setting.